TECON BIOLOGY Co.LTD (002100.SZ)
- Previous Close
6.75 - Open
6.40 - Bid 6.74 x --
- Ask 6.75 x --
- Day's Range
6.67 - 6.77 - 52 Week Range
6.15 - 9.08 - Volume
14,479,442 - Avg. Volume
22,141,073 - Market Cap (intraday)
9.215B - Beta (5Y Monthly) 0.63
- PE Ratio (TTM)
-- - EPS (TTM)
-0.34 - Earnings Date --
- Forward Dividend & Yield 0.22 (3.26%)
- Ex-Dividend Date Jun 16, 2023
- 1y Target Est
9.01
TECON BIOLOGY Co.LTD, together with its subsidiaries, engages in the provision of animal health care, feed, pig breeding, agricultural product processing and trade, and financial services in China and internationally. The company operates through five divisions: Feed, Pharmaceutical, Food Farming, Protein Oil, and Agricultural Products. The Feed division offers pigs, poultry, dairy cows, ruminants, aquatic feed products, as well as premixes and additives. The Pharmaceutical division researches and develops livestock and poultry disease vaccine products. The Food Farming division operates pig breeding, slaughtering, and segmentation facilities; provides deep processing of meat products; and cold chain distribution and sales. The Protein Oil division processes and produces cotton oil, meals, and shells, as well as linters. The Agricultural Products division engages in the acquisition and sale of agricultural and sideline products; crop drying, warehousing, logistics; agricultural machinery; grain storage equipment processing; import and export of goods and technology; processing, sales, agency business, etc. The company was formerly known as Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd. and changed its name to Tecon Biology Co.Ltd in June 2016. Tecon Biology Co.Ltd was founded in 1993 and is based in Urumqi, China.
www.tcsw.com.cn5,067
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 002100.SZ
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002100.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002100.SZ
Valuation Measures
Market Cap
9.22B
Enterprise Value
10.98B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.50
Price/Book (mrq)
1.29
Enterprise Value/Revenue
0.59
Enterprise Value/EBITDA
-37.26
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.48%
Return on Assets (ttm)
-1.35%
Return on Equity (ttm)
-6.14%
Revenue (ttm)
18.55B
Net Income Avi to Common (ttm)
-460.79M
Diluted EPS (ttm)
-0.34
Balance Sheet and Cash Flow
Total Cash (mrq)
3.84B
Total Debt/Equity (mrq)
63.73%
Levered Free Cash Flow (ttm)
-44.16M
Research Analysis: 002100.SZ
Company Insights: 002100.SZ
002100.SZ does not have Company Insights